INR Blood Test: Monitoring Warfarin Therapy and Clotting Function

The INR (International Normalized Ratio) standardizes prothrombin time (PT) results across laboratories. It measures how long blood takes to clot.

Primary Uses

  • Monitoring warfarin (Coumadin) anticoagulation therapy
  • Assessing liver disease or clotting disorders

Interpretation

  • Normal (off anticoagulants): 0.9–1.1
  • Therapeutic range (most warfarin indications): 2.0–3.0
  • High INR (>3–4): increased bleeding risk
  • Low INR (<2): increased clotting risk

Factors Affecting INR

Many drugs interact with warfarin and alter INR: antibiotics (e.g., trimethoprim-sulfamethoxazole), NSAIDs, aspirin, amiodarone, antifungals, herbal supplements (ginkgo, garlic), and dietary vitamin K changes.

Monitoring Frequency

Initially frequent (2–3×/week), then every 1–4 weeks once stable. Point-of-care testing enables rapid dose adjustment.

Blood Disorders - Related Articles